Clinical trial NCT00800904: Asthma Control Among Patients Receiving Inhaled Corticosteroids in Thailand
Official title: Asthma Control Among Patients Who Were Receiving Inhaled Corticosteroids in General Practice in Thailand
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Asthma
Keywords: Asthma
Inhaled corticosteroid
Thai patient eligibility
Persistent asthma
Lead sponsor: AstraZeneca
Sponsor class: INDUSTRY
First posted: 2008-12-02
Enrollment: 1210
Sex: ALL
Minimum age (years): 12
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Time perspective: RETROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patient aged 12 years and older who established persistent asthma and currently treated with any inhaled corticosteroid for 3 months or longer.

Brief summary: The purpose of this study is to determine the percentage of patients who has reached the GINA guideline of asthma treatment after receiving any inhaled corticosteroid for 3 months or longer in actual clinical practice. Such percentage for each level of severity - mild, moderate and severe persistent asthma as well as the differences of these rates will also be explored.


Eligibility criteria: Inclusion Criteria:

* Established persistent asthma
* Currently treated with any inhaled corticosteroid therapy but not SYMBICORT nor SERETIDE for 3 months or longer

Exclusion Criteria:

* Currently participating or have participated in a study with an investigational compound within the last 30 days
* Current diagnosis of chronic obstructive pulmonary disease (COPD)
* Smoked more than 10 packs a year

Primary outcomes:
measure: Asthma control test
timeFrame: On the survey date
Secondary outcomes:
measure: Asthma control in mild, moderate and severe persistent asthma patients
timeFrame: On the survey date
Other outcomes:
Locations:
city: Amnat Charoen
country: Thailand
facility: Research Site
city: Buriram
country: Thailand
facility: Research Site
city: Chachoengsao
country: Thailand
facility: Research Site
city: Chaiyaphum
country: Thailand
facility: Research Site
city: Chanthaburi
country: Thailand
facility: Research Site
city: Chiang Rai
country: Thailand
facility: Research Site
city: Kalasin
country: Thailand
facility: Research Site
city: Khon Kaen
country: Thailand
facility: Research Site
city: Lopburi
country: Thailand
facility: Research Site
city: Mae Hong Son
country: Thailand
facility: Research Site
city: Mahasarakham
country: Thailand
facility: Research Site
city: Nakhon Phanom
country: Thailand
facility: Research Site
city: Nakhorn Ratchasima
country: Thailand
facility: Research Site
city: Nan
country: Thailand
facility: Research Site
city: Nong Khai
country: Thailand
facility: Research Site
city: Samutsongkhram
country: Thailand
facility: Research Site
city: Si Sa Ket
country: Thailand
facility: Research Site
city: Singburi
country: Thailand
facility: Research Site
city: Songkla
country: Thailand
facility: Research Site
city: Sukhothai
country: Thailand
facility: Research Site
city: Surat Thani
country: Thailand
facility: Research Site
city: Trang
country: Thailand
facility: Research Site
city: Trat
country: Thailand
facility: Research Site
city: Ubon Ratchathani
country: Thailand
facility: Research Site
city: Udon Thani
country: Thailand
facility: Research Site
city: Yasothon
country: Thailand
facility: Research Site
Study officials:
affiliation: Department of Biostatistics and Demography, Faculty of Public Health, Khon Kaen University
name: Bandit Thinkhamrop, PhD
role: PRINCIPAL_INVESTIGATOR
affiliation: Department of Medicine, Faculty of Medicine, Khon Kaen University
name: Watchara Boonsawat, MD. PhD
role: PRINCIPAL_INVESTIGATOR
References: